About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT02624076

Acupuncture for Unexplained Subfertiliy

Infertility affects one in six couples. In a quarter of them, routine tests of semen quality, ovulation or tubal patency fail to reveal any abnormalities and the cause of infertility is unexplained. A...

Lead sponsor: Heilongjiang University of Chinese Medicine•16 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Hui Chang, MD

CONTACT

changhui1903@sina.com

Sponsors

Lead Sponsor

Heilongjiang University of Chinese Medicine

Age

18 - 40 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Women aged 18-40 years
•2. Bilateral patent tubes demonstrated by hysterosalpingogram, hysterosalpingo-contrast sonography or laparoscopy
•3. Regular menses 21 to 35 days Normal semen parameters :Total motile sperm count ≥10 million. (World Health Organization criteria, 2010)

Exclusion Criteria

•1. Unwillingness to accept either of the two interventions
•2. Contra-indications to acupuncture: pacemaker use or bleeding disorder
•3. Received acupuncture before 2 months for other diseases which are not related to unexplained infertility.
•4. Previously received acupuncture for unexplained infertility
•5. Use of hormonal or other medication (including Chinese Herbal prescriptions) which may affect the outcome in the past 2 months.
•6. Patients who anticipate taking longer than a one month break from treatment during the trial (i.e. 4 months from randomization).

Related studies

Varicocelectomy in Patients With Clinical Varicocele and Unexplained Infertility

NCT06491251 · Unexplained Infertility

Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

NCT06481696 · Unexplained Infertility

COMPLETEDPhase 4

Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone Levels

NCT04210765 · Unexplained Infertility, Ovulation Disorder

Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT

NCT01672801 · Unexplained Infertility, Polycystic Ovarian Syndrome, and more

A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility

NCT03386552 · Unexplained Infertility

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 21, 2015Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment1,423

Start dateDec 2015

Last updatedDec 21, 2015

Condition

Unexplained Infertility

Locations shown

Guangzhou Medical School First Affiliated Hospital

Guangzhou, Guangdong

The Daqing Oilfield General Hospital

Daqing, Heilongjiang

Daqing Longnan hospital

Daqing, Heilongjiang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 21, 2015Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions